Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-κ and heavy-chain gene rearrangements

Leukemia

Volumn 22, Issue 12, 2008, Pages 2265-2267

  Sutton, R ^a   Bahar, A Y ^a   Kwan, E ^a   Giles, J E ^a   Venn, N C ^a   Tran, S ^a   Hackenberg, N ^a   Pozza, L Dalla ^b   Marshall, G M ^a   Haber, M ^a   van der Velden, V H J ^c   Norris, M D ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; INTRON; LETTER; MINIMAL RESIDUAL DISEASE; MOLECULAR PROBE; MONITORING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 57849097518     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.121     Document Type: Letter

References (8)

1. Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S et al. Minimal residual disease (MRD)-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (ALL). Leukemia 2008; 22: 771-782.
2. van der Velden VHJ, Willemse MJ, van der Schoot CE, Hahlen K, van Wering ER, van Dongen JJM et al. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928-936.
3. Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426-1435.
4. Choi S, Henderson M, Kwan E, Beesley AH, Sutton R, Bahar AY et al. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood 2007; 110: 632-639.
5. Kwan E, Norris MD, Zhu L, Ferrara D, Marshall GM, Haber M et al. Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real-time polymerase chain reaction. Br J Haematol 2000; 109: 430-434.
6. van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grümayer R et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative data. Leukemia 2007; 21: 604-611.
7. Uchiyama M, Maesawa C, Yashima A, Itabashi T, Satoh T, Tarusawa M et al. Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3′ minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia. J Clin Pathol 2003; 56: 952-955.
8. van der Velden VHJ, Wijkhuijs MJ, Jacobs DCH, van Wering ER, van Dongen JJM. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: 1372-1380.